Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity

SARS-CoV-2 infection and its clinical manifestations (COVID-19) quickly evolved to a pandemic and a global public health emergency. The limited effectivity of available treatments aimed at reducing virus replication and the lessons learned from other coronavirus infections (SARS-CoV-1 or NL63) that...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Jorge, Santos, Catarina D., Fresco, Paula, Fernandez-Llimos, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999244/
https://www.ncbi.nlm.nih.gov/pubmed/36893838
http://dx.doi.org/10.1016/j.repc.2022.02.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999244/
https://www.ncbi.nlm.nih.gov/pubmed/36893838
http://dx.doi.org/10.1016/j.repc.2022.02.014

Ejemplares similares